Carl E. Schotborgh
About
Carl E. Schotborgh is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Carl E. Schotborgh has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 47 papers in Cardiology and Cardiovascular Medicine and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carl E. Schotborgh's work include Coronary Interventions and Diagnostics (48 papers), Acute Myocardial Infarction Research (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Carl E. Schotborgh is often cited by papers focused on Coronary Interventions and Diagnostics (48 papers), Acute Myocardial Infarction Research (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Carl E. Schotborgh collaborates with scholars based in Netherlands, Israel and Belgium. Carl E. Schotborgh's co-authors include Jan J. Piek, Karel T. Koch, Robbert J. de Winter, Matthijs Bax, Martijn Meuwissen, Clemens von Birgelen, Peter W. Danse, Carine J.M. Doggen, Elmir Ömerovic and Zsolt Piróth and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.
In The Last Decade
Carl E. Schotborgh
54 papers receiving 2.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carl E. Schotborgh Netherlands | 23 | 1.6k | 1.6k | 970 | 244 | 82 | 59 | 2.1k | ||
| Lamin King Germany | 20 | 1.3k 0.8× | 935 0.6× | 477 0.5× | 524 2.1× | 75 0.9× | 41 | 1.7k | ||
| Branko Beleslin Serbia | 20 | 620 0.4× | 1.1k 0.7× | 686 0.7× | 191 0.8× | 74 0.9× | 112 | 1.4k | ||
| Sunao Nakamura Japan | 24 | 1.5k 0.9× | 1.3k 0.8× | 908 0.9× | 596 2.4× | 114 1.4× | 184 | 2.1k | ||
| Gerrit Anne van Es Netherlands | 15 | 1.5k 0.9× | 1.4k 0.8× | 934 1.0× | 350 1.4× | 89 1.1× | 20 | 2.0k | ||
| Kenneth C. Huber United States | 16 | 1.7k 1.0× | 1.5k 0.9× | 990 1.0× | 563 2.3× | 100 1.2× | 26 | 2.3k | ||
| Giampaolo Cerisano Italy | 24 | 1.4k 0.8× | 2.2k 1.4× | 1.4k 1.4× | 147 0.6× | 215 2.6× | 49 | 2.7k | ||
| Keun Ho Park South Korea | 24 | 928 0.6× | 914 0.6× | 523 0.5× | 242 1.0× | 109 1.3× | 156 | 1.6k | ||
| Marie Claude Morice France | 17 | 1.8k 1.1× | 1.7k 1.1× | 1.2k 1.3× | 406 1.7× | 111 1.4× | 39 | 2.2k | ||
| Tetsuo Matsubara Japan | 20 | 1.4k 0.8× | 807 0.5× | 1.2k 1.3× | 452 1.9× | 286 3.5× | 42 | 1.9k | ||
| Roberto Violini Italy | 24 | 1.6k 1.0× | 1.7k 1.0× | 796 0.8× | 449 1.8× | 60 0.7× | 83 | 2.1k |
Countries citing papers authored by Carl E. Schotborgh
Since
Specialization
Citations
This map shows the geographic impact of Carl E. Schotborgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Schotborgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Schotborgh more than expected).
Fields of papers citing papers by Carl E. Schotborgh
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Carl E. Schotborgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Schotborgh. The network helps show where Carl E. Schotborgh may publish in the future.
Co-authorship network of co-authors of Carl E. Schotborgh
This figure shows the co-authorship network connecting the top 25 collaborators of Carl E. Schotborgh. A scholar is included among the top collaborators of Carl E. Schotborgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl E. Schotborgh. Carl E. Schotborgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ploumen, Eline H., Rosaly A. Buiten, Carine J.M. Doggen, et al.. (2024). Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years. PharmacoEconomics - Open. 9(1). 137–145.
2.
Ploumen, Eline H., Marlies M. Kok, Carl E. Schotborgh, et al.. (2024). Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease. Cardiovascular Intervention and Therapeutics. 40(2). 287–295.
3.
Ploumen, Eline H., Carine J.M. Doggen, Carl E. Schotborgh, et al.. (2024). Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials. Netherlands Heart Journal. 32(6). 254–261.
4.
Berg, Jurriën M. ten, Joanna J. Wykrzykowska, Niels van Royen, et al.. (2023). Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Netherlands Heart Journal. 31(12). 489–499.
5.
Ploumen, Eline H., Rosaly A. Buiten, Paolo Zocca, et al.. (2022). Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers. Journal of the American Heart Association. 11(22). e026041–e026041.
6.
Latib, Azeem, Pierfrancesco Agostoni, Jo Dens, et al.. (2021). Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study. The Journal of invasive cardiology. 33(11). E863–E869.
7.
Abu‐Hanna, Ameen, Bas A.J.M. de Mol, Saskia Houterman, et al.. (2020). External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration. International Journal of Cardiology. 317. 25–32.
8.
Oemrawsingh, Rohit M., Folkert W. Asselbergs, Anho Liem, et al.. (2019). Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study). The American Journal of Cardiology. 124(1). 8–13.
9.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2019). Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents. JACC: Cardiovascular Interventions. 12(17). 1650–1660.
10.
Kok, Marlies M., Clemens von Birgelen, Naveed Sattar, et al.. (2018). Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention. 14(9). e1049–e1056.
11.
Smits, Pieter C., Elmir Ömerovic, Mohamed Abdel‐Wahab, et al.. (2018). TWO YEAR RESULTS FROM THE COMPARE-ACUTE TRIAL. Journal of the American College of Cardiology. 71(11). A1158–A1158.
12.
Birgelen, Clemens von, Paolo Zocca, Rosaly A. Buiten, et al.. (2018). Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial. The Lancet. 392(10154). 1235–1245.
13.
Smits, Pieter C., Mohamed Abdel‐Wahab, Franz–Josef Neumann, et al.. (2017). Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial Infarction. New England Journal of Medicine. 376(13). 1234–1244.
14.
Heijden, Liefke C. van der, Marlies M. Kok, Paolo Zocca, et al.. (2017). Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial. American Heart Journal. 198. 25–32.
15.
Bax, Matthijs, Carl E. Schotborgh, Pranobe V. Oemrawsingh, et al.. (2015). The impact of gender on long-term mortality in patients with multivessel disease after primary percutaneous coronary intervention. Netherlands Heart Journal. 23(12). 592–599.
16.
Smits, Pieter C., Georgios J. Vlachojannis, Ketil Lunde, et al.. (2014). TCT-328 FFR-guided complete revascularization during primary PCI: Preliminary data from the COMPARE ACUTE trial. Journal of the American College of Cardiology. 64(11). B95–B95.
17.
Rittersma, Saskia Z.H., Robbert J. de Winter, Karel T. Koch, et al.. (2004). Impact of strut thickness on late luminal loss after coronary artery stent placement. The American Journal of Cardiology. 93(4). 477–480.
18.
Chamuleau, Steven A. J., Martijn Meuwissen, Berthe L.F. van Eck‐Smit, et al.. (2001). Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestambi single-photon emission computed tomography in patients with two-vessel coronary artery disease. Journal of the American College of Cardiology. 37(5). 1316–1322.
19.
Liebergen, Rob A.M van, Jan J. Piek, Ron J.G. Peters, et al.. (1999). Hyperemic coronary flow after optimized intravascular ultrasound-guided balloon angioplasty and stent implantation. Journal of the American College of Cardiology. 34(7). 1899–1906.
20.
Liebergen, Rob A.M van, Jan J. Piek, Karel T. Koch, et al.. (1999). Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables. Journal of the American College of Cardiology. 33(3). 670–677.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lamin King Breakdown of academic impact, for papers by Branko Beleslin Breakdown of academic impact, for papers by Sunao Nakamura Breakdown of academic impact, for papers by Gerrit Anne van Es Breakdown of academic impact, for papers by Kenneth C. Huber Breakdown of academic impact, for papers by Giampaolo Cerisano Breakdown of academic impact, for papers by Keun Ho Park Breakdown of academic impact, for papers by Marie Claude Morice Breakdown of academic impact, for papers by Tetsuo Matsubara Breakdown of academic impact, for papers by Roberto Violini